ANTHEM vs RELIANCE
Head-to-head DCF comparison · Anthem Biosciences Limited vs Reliance Industries
Model Favors
RELIANCE shows a larger model margin of safety
Leads on 3 of 4model metrics · not investment advice
ANTHEM
Anthem Biosciences Limited
General/Diversified
₹722
OvervaluedRELIANCE
Reliance Industries
Oil & Gas
₹1,353
Fairly Valued| Metric | ANTHEM | RELIANCE |
|---|---|---|
| Verdict | Overvalued | Fairly Valued |
| YieldIQ Score | 53/100 | 66/100 |
| Fair Value | ₹172 | ₹1,471 |
| Current Price | ₹722 | ₹1,353 |
| Margin of Safety | -76.1% | +8.7% |
| Moat | Moderate | Wide |
| Piotroski F-Score | 7/9 | 5/9 |
| ROE | 18.7% | — |
| Debt / Equity | — | 0.36 |
| EV / EBITDA | 48.8× | 12.8× |
| Market Cap | ₹0.41 Lakh Cr | ₹18.31 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.